Digital Markers for Behavioral Symptoms in Dementia Care

Original Title: Dementia Care Research and Psychosocial Factors

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

DOI: 10.1002/alz70858_100300

Overview

Overview
This study investigates the utility of Real-Time Location Systems (RTLS) in inpatient dementia care units to monitor behavioral and psychological symptoms. While these systems are primarily deployed for safety and nurse calls, the research explores their potential to provide longitudinal insights into resident health. The Space-Time Indices for Clinical Support project utilized data from 47 participants with a mean Mini-Mental State Examination score of 5 out of 30. Over an average of seven weeks per participant, location data was used to build machine learning models for detecting motor agitation and identifying rest-activity rhythms. Results showed that models could distinguish motor agitation from normal activities with an Area Under the Receiver Operating Characteristic curve (AUROC) of 0.81. Furthermore, the analysis identified six distinct digital phenotypes for rest-activity, ranging from well-regulated circadian rhythms to severe rhythm disturbances.

Novelty

Novelty
The primary innovation lies in repurposing existing infrastructure within care facilities to derive clinical markers without requiring additional wearable sensors that residents might find intrusive. Unlike traditional methods relying on periodic manual observations, this approach utilizes continuous spatio-temporal data to quantify behavior. The study employed SHAP explainability analysis to determine that 17 of the top 20 model features for agitation detection were derived directly from the location system, with movement speed and total distance serving as the key predictors. Additionally, the application of unsupervised deep learning to identify six specific rest-activity profiles represents a shift toward data-driven phenotyping. This allows for the categorization of residents into groups such as those with high night activity or significant day-to-day instability, providing a nuanced understanding of behavioral patterns often difficult to capture through standard clinical scales.

Potential Clinical / Research Applications

Potential Clinical / Research Applications
These findings suggest that location data can be integrated into clinical decision support systems to help staff monitor the effectiveness of behavioral interventions or medication changes in real-time. Clinicians can use the identified rest-activity phenotypes to tailor individualized care plans, such as adjusting light exposure for residents in the high night activity cluster. In research settings, these digital markers provide objective, continuous endpoints for clinical trials, reducing the burden on caregivers to complete subjective rating scales. Future studies could expand this work by validating these markers across diverse long-term care environments and exploring how these patterns correlate with long-term cognitive decline.

Similar Posts

  • A study of 950 AI medical devices found that lack of clinical validation and public company status were linked to higher odds of early recalls.

    Original Title: Early Recalls and Clinical Validation Gaps in Artificial Intelligence-Enabled Medical Devices Journal: JAMA health forum DOI: 10.1001/jamahealthforum.2025.3172 AI Medical Device Recalls and Validation Gaps Overview Artificial intelligence-enabled medical devices (AIMDs) are increasingly common in clinical practice, yet many receive US Food and Drug Administration (FDA) clearance through an accelerated pathway that does not require prospective human testing. This raises concerns about their performance and safety after entering the market. This study investigated the frequency of recalls among AIMDs and examined whether recalls were associated with two key factors: the lack of premarket clinical validation and the type of manufacturer (publicly traded vs. privately held). Researchers analyzed 950 FDA-cleared…

  • Amyloid and Vascular Subtypes in Alzheimer’s Disease

    Original Title: Biomarkers Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association DOI: 10.1002/alz70856_100574 Overview Alzheimer’s disease is a heterogeneous condition often occurring alongside cerebral small vessel disease. This study examines 262 individuals across two cohorts: the longitudinal TRIAD cohort, representing a low burden of small vessel disease, and the MITNEC-C6 cohort, which includes real-world patients with mixed dementia and moderate-to-severe vascular lesions. Using a deep learning segmentation tool and the Subtype and Stage Inference algorithm, the research team identified distinct imaging-derived subtypes based on amyloid deposition, white matter hyperintensities, perivascular spaces, and diffusion markers. The study tracked 202 individuals at baseline, with follow-ups at two and three…

  • Robust CRC Diagnosis via Causal and Uncertainty-Aware AI

    Original Title: Uncertainty-aware and causal test-time adaptive foundation model for robust colorectal cancer pathology diagnosis Journal: NPJ digital medicine DOI: 10.1038/s41746-025-02149-1 Overview Colorectal cancer remains a major global health challenge, requiring precise histopathological analysis for effective treatment. While computational pathology has advanced with the use of large-scale foundation models, these systems frequently encounter obstacles when deployed in real-world clinical settings. Key issues include domain shifts caused by variations in staining protocols and scanner hardware, as well as the tendency for models to provide overconfident yet incorrect predictions. This paper introduces UAD-FM, an uncertainty-aware and causally adaptive foundation model designed to address these limitations. The framework integrates a variational Bayesian approach…

  • Learning interpretable network dynamics via universal neural symbolic regression

    Unveiling System Dynamics with Neural Symbolic Regression One-Sentence Summary The paper introduces a computational tool, Learning Law of Changes (LLC), that combines neural networks and symbolic regression to automatically discover the mathematical equations governing complex network dynamics from observational data. Overview Understanding the behavior of complex systems, such as biological networks or epidemic spreads, is a fundamental challenge in science. These systems are often governed by underlying mathematical rules, typically in the form of differential equations. However, identifying these exact equations from data alone is notoriously difficult. This paper presents a novel computational framework named LLC designed to tackle this problem. The method first employs neural networks to learn the…

  • AI Tools for Cognitive Support in Professional Settings

    Original Title: Dementia Care Research and Psychosocial Factors Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association DOI: 10.1002/alz70858_104857 Overview The research investigates the role of artificial intelligence in supporting individuals working with Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), or early-onset dementia. Employment retention is a significant challenge for this population, as cognitive changes often lead to premature retirement. Traditional adjustments, like reduced hours or simplified tasks, often fail to address underlying difficulties effectively. This qualitative study involved two rounds of one-hour semi-structured interviews with 11 participants currently employed in diverse roles, including lawyers, therapists, and engineers, across industries like manufacturing and hospitality. The first phase…

  • AI Model Variability in EGFR Prediction by Ancestry

    Original Title: Ancestry-Associated Performance Variability of Open-Source AI Models for EGFR Prediction in Lung Cancer Journal: JAMA oncology DOI: 10.1001/jamaoncol.2025.6430 Overview This study evaluates the performance and generalizability of two open-source artificial intelligence models, EAGLE and DeepGEM, for predicting "EGFR" mutation status in lung adenocarcinoma using routine hematoxylin-eosin pathology slides. Researchers analyzed 2098 patients across two independent cohorts: the Dana-Farber Cancer Institute and the European TNM-I trial. The primary objective was to determine if these AI tools maintain accuracy across different ancestral backgrounds and anatomical sample types. Results indicated that the EAGLE model achieved an area under the receiver operating characteristic curve of 0.83 in the first cohort and 0.81…

Leave a Reply

Your email address will not be published. Required fields are marked *

CAPTCHA